Clinical Trial Update: DORA: A Doravirine-based First-line Antiretroviral Therapy for Women of Reproductive Potential Living With HIV [Phase 3]

View source ↗

Summary

Phase 3 trial assessing a doravirine-based first-line antiretroviral therapy for women of reproductive potential with HIV-1 infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DORAVIRINE-based regimen (doravirine-based regimen)

Snippet

Sponsor: Professor Francois Venter | Conditions: HIV-1-infection | Phase 3 | Status: COMPLETED